These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 22349584)

  • 1. Water molecule movement may be the key to monitoring success of ovarian cancer treatment.
    Mayor S
    BMJ; 2012 Feb; 344():e1229. PubMed ID: 22349584
    [No Abstract]   [Full Text] [Related]  

  • 2. Light-based imaging of green fluorescent protein-positive ovarian cancer xenografts during therapy.
    Chaudhuri TR; Mountz JM; Rogers BE; Partridge EE; Zinn KR
    Gynecol Oncol; 2001 Sep; 82(3):581-9. PubMed ID: 11520161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of CA125 in patients with ovarian cancer--usefulness in periodical monitoring.
    Kawai M; Inagaki S; Yamashita H; Imaizumi H; Kakihara M; Arii Y
    Nihon Gan Chiryo Gakkai Shi; 1988 May; 23(5):1059-67. PubMed ID: 3166484
    [No Abstract]   [Full Text] [Related]  

  • 4. Intracellular lipid in ovarian thecomas detected by dual-echo chemical shift magnetic resonance imaging: report of 2 cases.
    Okajima Y; Matsuo Y; Tamura A; Irie H; Nakazono T; Hara Y; Suzuki K; Yamasaki F; Kudo S; Saida Y
    J Comput Assist Tomogr; 2010; 34(2):223-5. PubMed ID: 20351509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Magnetic resonance imaging of cystic ovarian tumors].
    Joja I; Shimizu M; Yamamoto Y; Yamamoto H; Hayashi H; Miyake M; Hashimoto K; Sugita K; Hiraki Y; Aono K
    Rinsho Hoshasen; 1987 Mar; 32(3):401-5. PubMed ID: 3613173
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical markers in ovarian cancer.
    Kiricuta I; Bojan O; Munteanu S
    Arch Geschwulstforsch; 1986; 56(1):35-8. PubMed ID: 3964031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian cancer patient surveillance after curative-intent initial treatment.
    Harmandayan GZ; Gao F; Mutch DG; Virgo KS; Gibb RK; Johnson FE
    Gynecol Oncol; 2011 Feb; 120(2):205-8. PubMed ID: 21075437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo detection of choline in ovarian tumors using 3D magnetic resonance spectroscopy.
    Esseridou A; Di Leo G; Sconfienza LM; Caldiera V; Raspagliesi F; Grijuela B; Hanozet F; Podo F; Sardanelli F
    Invest Radiol; 2011 Jun; 46(6):377-82. PubMed ID: 21467947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Magnetic resonance spectroscopy of breast cancer].
    Knopp MV; Hess T; Bachert P; Ende G; Junkermann H; Hesterkamp T; van Kaick G
    Radiologe; 1993 May; 33(5):300-7. PubMed ID: 8516439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian fibromatosis: magnetic resonance imaging findings with pathologic correlation.
    Takeuchi M; Matsuzaki K; Sano N; Furumoto H; Nishitani H
    J Comput Assist Tomogr; 2008; 32(5):776-7. PubMed ID: 18830110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Magnetic resonance tomography in oncologic gynecology].
    Dudarev AL; Vinokurov VL; Shelkoplias EN; Goritskaia IV
    Vestn Rentgenol Radiol; 1993; (5):14-5. PubMed ID: 7801576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The usefulness of MRI in the evaluation of hormonal therapy of ovarian chocolate cysts].
    Sugimura K; Ishida T; Takemori M; Kono M; Yamasaki K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Sep; 48(9):1186-8. PubMed ID: 3200701
    [No Abstract]   [Full Text] [Related]  

  • 13. [Imaging procedures in diagnosis of ovarian carcinoma].
    Häusler G; Schurz B
    Wien Med Wochenschr; 1996; 146(1-2):8-10. PubMed ID: 8835488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of ovarian tumors by proton magnetic resonance spectroscopy at three Tesla.
    Stanwell P; Russell P; Carter J; Pather S; Heintze S; Mountford C
    Invest Radiol; 2008 Oct; 43(10):745-51. PubMed ID: 18791417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring cancer by magnetic resonance.
    Stubbs M; Griffiths JR
    Br J Cancer; 1999 Jul; 80 Suppl 1():86-94. PubMed ID: 10466766
    [No Abstract]   [Full Text] [Related]  

  • 16. A rare case of ovarian carcinosarcoma successfully treated with the neoadjuvant chemotherapy of paclitaxel and ifosfamide.
    Okazawa M; Masuhara K; Miyoshi A; Fujiwara K; Ohta Y; Yoshino K; Kamiura S; Tomita Y
    J Obstet Gynaecol; 2011; 31(3):274-5. PubMed ID: 21417665
    [No Abstract]   [Full Text] [Related]  

  • 17. Investigating women with suspected ovarian cancer.
    Spencer JA; Forstner R; Hricak H
    Gynecol Oncol; 2008 Feb; 108(2):262-4. PubMed ID: 18023850
    [No Abstract]   [Full Text] [Related]  

  • 18. [The role of magnetic resonance imaging in the evaluation of ovarian tumors in pregnancy].
    Hamada H; Someya K; Sohda S; Kubo T
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Mar; 44(3):361-4. PubMed ID: 1607761
    [No Abstract]   [Full Text] [Related]  

  • 19. Trophinin is a potent prognostic marker of ovarian cancer involved in platinum sensitivity.
    Baba T; Mori S; Matsumura N; Kariya M; Murphy SK; Kondoh E; Kusakari T; Kuroda H; Mandai M; Higuchi T; Takakura K; Fukuda MN; Fujii S
    Biochem Biophys Res Commun; 2007 Aug; 360(2):363-9. PubMed ID: 17597582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging in an experimental model of human ovarian cancer demonstrating altered microvascular permeability after inhibition of vascular endothelial growth factor.
    Gossmann A; Helbich TH; Mesiano S; Shames DM; Wendland MF; Roberts TP; Ferrara N; Jaffe RB; Brasch RC
    Am J Obstet Gynecol; 2000 Oct; 183(4):956-63. PubMed ID: 11035346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.